Journal
CELLS
Volume 11, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/cells11091484
Keywords
Golgi; secretion; cancer secretome; metastasis; invasion; EMT; cancer therapeutics; biomarkers
Categories
Funding
- NIH [R37CA214609, 2P50CA070907-21A]
- Rexanna's Foundation for Fighting Lung Cancer
- CPRIT Research Training Grant [RP170067]
- CPRIT-MIRA [RP160652-P3]
Ask authors/readers for more resources
The Golgi apparatus plays a crucial role in protein processing and trafficking in normal cells. Aberrant Golgi dynamics in cancer alter the tumor microenvironment and the immune landscape, enhancing the invasive and metastatic potential of cancer cells.
The Golgi apparatus is at the center of protein processing and trafficking in normal cells. Under pathological conditions, such as in cancer, aberrant Golgi dynamics alter the tumor microenvironment and the immune landscape, which enhances the invasive and metastatic potential of cancer cells. Among these changes in the Golgi in cancer include altered Golgi orientation and morphology that contribute to atypical Golgi function in protein trafficking, post-translational modification, and exocytosis. Golgi-associated gene mutations are ubiquitous across most cancers and are responsible for modifying Golgi function to become pro-metastatic. The pharmacological targeting of the Golgi or its associated genes has been difficult in the clinic; thus, studying the Golgi and its role in cancer is critical to developing novel therapeutic agents that limit cancer progression and metastasis. In this review, we aim to discuss how disrupted Golgi function in cancer cells promotes invasion and metastasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available